"The commercialization of medical AI and the application of innovative technologies" have undoubtedly become high-frequency words in the medical industry in 2021.
On the one hand, the new technology represented by artificial intelligence, after several years of polishing in the upstream and downstream of the medical industry, clearly exerted the application value of auxiliary diagnosis, clinical decision-making, scientific research cooperation, etc., how to clarify its development model and form a continuous iterative industrial paradigm has become the most important thinking of this year's industry.
On the other hand, innovative means and tools such as Internet diagnosis and treatment, digital intelligence, protein computing chips, oral surgery + logistics robots, etc., have also taken root in all aspects of the medical system this year, trying to solve more modern medical problems and provide new ideas for traditional diagnosis and treatment methods.
Medical care has always been a traditional industry, the traditional model and supply and demand relationship of treating patients and saving people, seeing patients and consulting, have not changed for thousands of years; the medical industry has always been breaking the tradition, from penicillin to roentgen radiation to genomics, every technological innovation has brought about earth-shaking changes.
We firmly believe that in this small change, there will be many shining points worth remembering.
With this, in 2021, Leifeng launched the "2021 Best AI Digital Intelligence Annual List", which was upgraded from the "AI Best Nugget Annual List" and officially launched in 2017, which is the first artificial intelligence business project list selection activity in China.
In the past four years, nearly 2,000 companies have participated in the election, and after multiple rounds of screening and review, nearly 200 companies with great commercial value have successfully escaped from the list and been selected for four lists, becoming the king of various fields.
At the end of the upcoming year, the 2021 Best AI Digital Intelligence Annual List will launch a new round of selection, and continue to look for digital intelligence pilot enterprises in more than 10 industries such as AI+ medical, intelligent driving, industry, future cities, finance, security, etc., as well as their digital intelligence benchmarking projects, to make authoritative references and project introductions for decision-makers in the five industries of government, industry, academia, research and investment.
AI is the body, the scene is used. At the level of technology scenario-based landing, the evaluation indicators of the "2021 Best AI Digital Intelligence Annual List" will include single-scenario depth/full-scenario service capabilities, upstream and downstream industry chain discourse power, core technology independent originality, POC test comprehensive results, and international/national standard formulation experience.
Among them, in the field of "medical technology scenes", Huiyi Huiying, Shenrui Medical, Keya Medical, Yizhun Intelligence, BAHEAL Intelligent Technology, Ping An Health (Testing) Center, Tencent Health, and Batu Biotech were successfully selected into the 2021 Best AI Digital Intelligence Annual List, and won the Best Innovative Medical Device Award, the Best Smart Medical Science and Education Platform Award, the Best Clinical Auxiliary Decision-making Award, the Best Two Cancer Screening and Public Health Empowerment Award, the Best Regional Imaging Cloud Platform Award, the Best Third-Party Imaging Diagnostic Institution Award, respectively, Best Smart Hospital Process Optimization Award, Best AI New Drug Development Platform Award (the above ranking is in no particular order).
Best Innovative Medical Device Award: Huiyi Huiying
Huiyi Huiying is a national medical imaging artificial intelligence high-tech enterprise dedicated to the application of computer vision and deep learning technology.
Relying on the core technology of image deep learning and a number of patented technologies, based on cloud computing, big data and artificial intelligence technology, Huiyi Huiying currently has three major product systems to complete the closed loop from screening, diagnosis and treatment decision support. The company explores the value of data resources industry-leading and continuous growth, Huiyi Huiying cut into the data bank with images, successfully connected hospitals and formed a data closed loop.
At present, Huiyi Huiying's AI products have covered more than 50 countries around the world, and more than 1,000 domestic provincial and municipal health systems, hospitals at all levels, and large physical examination centers, using AI technology to open up the global market, and defeating many national opponents in two consecutive global algorithm competitions to win the first and second places.
During the COVID-19 period, the Prime Minister of Thailand, the Vice President of Ecuador, the Ministers of Health of Malaysia and Chile and others liked the technology of Huiyi Huiying on social media, becoming an overseas medical AI star enterprise.
Huiyi Huiying, with industry,000 as the technical gene, won 3 National Natural Science Foundations at the same time in 2021, and has published 64 SCI papers and 67 abstract articles in cooperation with hospitals, and undertaken a number of national and Beijing municipal science and technology commission projects. Won the People's Daily "Healthy China" annual top ten AI medical innovation project, Red Herrin (Red Herrin) Asia's top 100, Forbes China's top 50 most innovative enterprises and other honors.
Best Smart Medicine Science and Education Platform Award: Shenrui Medical
Founded in March 2017, Shenrui Medical is committed to providing artificial intelligence and Internet medical solutions for domestic and foreign medical service institutions through breakthrough artificial intelligence technology and independently developed core algorithms, Shenrui Medical gathers professionals in artificial intelligence, Internet cloud computing, medical imaging and other fields, and the company's core team is composed of senior practitioners in the medical field and doctors and senior researchers from well-known universities at home and abroad.
At present, the company has built a medical artificial intelligence ecosystem including smart imaging, smart services, smart scientific research, smart cloud, smart education, etc., which can provide artificial intelligence services from auxiliary diagnosis, patient services, scientific research, and doctor training.
This year, Shenrui Medical's new smart medical education products were officially released, deeply excavating the information contained in medical big data, and providing doctors with a new model of professional training and education through NLP and clinical knowledge graph technology. The platform integrates the disease knowledge map and builds a novel intelligent expert teaching system, covering the four functions of learning, teaching, training and research.
Through practical training, cultivate doctors' scientific diagnostic thinking, the platform can provide auxiliary detection functions for medical images with multiple diseases and multiple signs, combine clinical information, laboratory examination data and other multi-dimensional characteristics, dig deep into the information contained in medical big data, and provide rich diagnostic teaching application scenarios for cultivating young physicians.
Best ClinicalLy Assisted Decision-Making Product Award: Keya Medical
Founded in January 2016, Keya Medical is the first enterprise in China to certify the three types of AI medical devices, and is also the first international leader in artificial intelligence medical care with China's NMPA, the US FDA, and the EU CE triple certification products.
Focusing on the application of big data and artificial intelligence technology in the medical field, Keya Medical is committed to empowering the medical industry with AI technology, promoting the clinical path to achieve accurate diagnosis and treatment, creating a new generation of artificial intelligence medical platform, and providing accurate medical services for patients, medical institutions and life science research institutions.
Based on AI technology, Keya Medical builds an AI product service system covering the whole process from screening, diagnosis to treatment and follow-up from the coronary pulse product line, and helps the improvement of the AI medical industry chain. Keya Medical has more than 10 products in the series of smart heart, smart brain and smart image.
At present, Keya Medical has successfully built more than 1,100 artificial intelligence diagnostic centers with benchmark hospitals in many provinces and cities in China, of which 80% are tertiary hospitals, and have approved prices in 8 provinces, and prices in 13 provinces are under approval, covering more than 30 million patients. At the same time, in the international market, we actively explore technical boundaries and incubate industry scenario applications.
Best Two Cancer Screening and Public Health Empowerment Award: Medical Quasi-Intelligence
Founded at the end of 2017, Beijing Medical Intelligence brings together the top artificial intelligence and medical industry elites at home and abroad, and is committed to creating a full-stack intelligent analysis solution from the perspective of solving the actual needs of the clinic.
According to the latest data in 2020, the number of new breast cancers reached 2.26 million, and breast cancer officially replaced lung cancer as the world's largest cancer. The screening of two cancers has also been highly concerned by the national governments at all levels, and the 2021 National Cancer Center Guidelines for Screening and Early Diagnosis and Early Diagnosis of Chinese Women's Breast Cancer point out that early breast cancer screening should be carried out for general risk groups and high-risk groups.
Since its inception, Medical Intelligence has taken the care of women's health as one of its development goals, from in-depth analysis of breast cancer screening pain points to the use of artificial intelligence technology to achieve the whole process coverage of breast health programs from static analysis to dynamic real-time, from single device to full modal, from diagnostic analysis to full-stack analysis, and launched a full-stack intelligent analysis solution for breast glands, covering conventional breast cancer screening equipment, truly combining movement and static. And in 2021, he created the "Pink Guan AI" brand branch line, practiced the original intention of pink, and injected AI power into women's health care. More possibilities are realized on the important concept of early screening, early diagnosis and early treatment of breast cancer and the protection of women's breast health.
Best Regional Image Cloud Platform Award: BAHEAL Intelligent Technology
As a medical information upgrading service provider featuring AI, BAHEAL Intelligent Technology is based on the pre-structured medical data and AI algorithm technology platform, oriented by the industrialization of innovative products, providing the whole chain and multi-scenario overall solutions for the government, hospitals, pharmaceutical companies, doctors and patients, and is committed to improving health with science and technology.
At present, more than a dozen top hospitals in the United Nations have developed medical AI applications in different medical scenarios, optimized medical scenarios with smart medical technology, demonstrated strong medical AI application research and development and promotion capabilities, and also helped hospitals to build intelligently in supporting medical informatization upgrades.
Up to now, BAHEAL Intelligent Technology and its holding subsidiaries have hundreds of independent intellectual property rights and applied for dozens of invention patents. In the future, BAHEAL Intelligent Technology will continue to increase investment in research and development, further expand the advantages of the industry with innovative and independently developed high-tech products, and continue to innovate and pursue excellence.
Best Third-Party Imaging Diagnostics Institution Award: Ping An Health (Testing) Center
Ping An Health (Testing) Center is an important member of Ping An University of China's medical and health sector, to promote graded diagnosis and treatment, promote the development of health business, realize the sharing of regional medical resources, rely on scientific research-level cutting-edge equipment, imaging experts, nano-level precision technology, better customer experience and medical-grade health testing, to create offline and online integrated imaging diagnosis, medical inspection and precision examination comprehensive medical service format, to provide the broad masses of people with more convenient, more accurate and safer innovative health testing services.
Up to now, Ping An Health (Testing) Center has completed the network layout of 8 self-operated flagship testing centers and 9 medical laboratories nationwide, and has landed more than 600 medical terminals in 27 provinces through co-construction, franchise, hosting, and mobile.
As a third-party medical institution, Ping An Health (Testing) Center has always been committed to improving regional medical technology service capabilities, actively responding to the national policy of graded diagnosis and treatment, undertaking multi-level medical service functions, promoting the sharing of regional medical resources, and resolving social problems with uneven medical resources.
In terms of medical service capabilities, Ping An Health (Testing) Center has set up a full-time medical team composed of authoritative experts and middle-aged and young backbones of top three hospitals, and introduced 256 low-dose spiral CT, 3.0T magnetic resonance, PET/CT and other top medical equipment to create a solid medical quality.
Best Smart Hospital Process Optimization Award: Tencent Health
Tencent Health is a medical and health platform that provides users with online and offline integrated services, using its advantages in connectivity and technology to connect more than 3,000 public hospitals across the country, help hospitals to carry out digital upgrades, explore the upgrading of the "Internet + medical health" application model with all parties in the industry, jointly release the value of high-quality medical resources on the medical supply side, help hospitals improve patient experience and efficiency, and meet patients' "simpler medical treatment" demands.
In March 2021, the First Affiliated Hospital of Guangxi Medical University joined hands with Tencent Health, Guangxi he cham technology to comprehensively digitally upgrade medical services using Internet technology: more than 4,000 medical staff of the First Affiliated Hospital of Medical University were connected to Tencent Health to open online outpatient clinics, and the "Internet + Nursing" on-site service and integrated medical services based on the cloud medical consortium were also launched simultaneously.
By opening the "Medical Health" in the WeChat Payment interface, users can quickly enter the First Affiliated Hospital of the University of Medicine and enjoy online and offline integrated medical and health services covering the whole cycle of pre-diagnosis, diagnosis and post-diagnosis, including AI guidance and intelligent pre-consultation, so as to optimize the whole process of medical and health experience optimization and health tracking, making it easier to seek medical treatment.
Best AI New Drug Development Platform Award: Baektu Biotech
Batu Biogenera uses ultra-large-scale graph neural networks to extract high-dimensional targets and disease association laws from massive biological data.
The company has established high-throughput automation laboratories of more than 10,000 square meters in Beijing and Suzhou, and has built unique cell and organ models through independent research and development of micro-scale, high-throughput, ultra-resolution and other technical capabilities, and obtained high-quality verification data. On this basis, through the active and reinforcement learning methods of dry and wet closed-loop experiments, the design and understanding process of antibody drugs is greatly accelerated, so as to design advanced and complex next-generation antibodies.
Relying on the strong underlying capabilities of unique partners such as Baidu Intelligent Cloud, Batu Biotech has developed supercomputing clusters, high-performance protein computing chips, high-performance graph databases, and high-level data security and privacy computing engines for biological computing needs, supporting exabyte-level massive data storage computing needs, making it possible to make ultra-large-scale protein pre-training models, graph neural network target analysis, protein structure prediction and simulation possible.
![Hard work to win the battle, FAW-Volkswagen "zhongzhi" year is determined to win[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)